Cargando…
Insights on β‐blockers for the treatment of hypertension: A survey of health care practitioners
A quantitative survey was completed by 103 primary care physicians (PCPs) and 59 cardiologists who regularly prescribed β‐blockers to assess knowledge and use of this heterogeneous drug class for hypertension. More cardiologists than PCPs chose β‐blockers as initial antihypertensive therapy (30% vs...
Autores principales: | Egan, Brent, Flack, John, Patel, Mehul, Lombera, Sofia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220865/ https://www.ncbi.nlm.nih.gov/pubmed/30289609 http://dx.doi.org/10.1111/jch.13375 |
Ejemplares similares
-
Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
por: Basile, Jan, et al.
Publicado: (2018) -
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma
por: Pasquier, E, et al.
Publicado: (2013) -
β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012) -
Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study
por: Fong, Regan, et al.
Publicado: (2018) -
Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study
por: Reddy Peddi, Divya, et al.
Publicado: (2023)